Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patients
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Join us for an insightful session on how our single-tube NGS solution can provide a complete genetic profile for thalassemia testing within 24 hours, reducing laboratory workflow time by weeks and significantly shortening the time to completion of the full clinical workflow.
Dr. Thessalia Papasavva, from the Cyprus Institute of Neurology and Genetics, will share her experiences in fully implementing an NGS solution in their routine lab for thalassemia genetic testing. Join us as we discuss new ways of working, experiences, and considerations from implementing NGS in routine labs, and NGS data analysis simplified with customized software.
During the webinar we will discuss:
News | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in ChinaDevyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Read More
Read More
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Read More
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Read More